Navigation Links
Rest for the Weary: Pain Relief for Diabetics with Painful Neuropathy
Date:11/5/2013

WALTHAM, Mass., Nov. 5, 2013 /PRNewswire/ -- Way back in the 17th century, John Donne, English attorney, cleric and preeminent representative of the metaphysical poets, wrote: "Sleep is pain's easiest salve, as doth fulfill all offices of death, except to kill." Today, those words could especially resonate with the estimated three to five million U.S. men and women with Type 2 diabetes who suffer from Painful Diabetic Neuropathy (PDN), as half of them report trouble falling or remaining asleep.

PDN is a manifestation of diabetic neuropathy, a common complication of diabetes that results from nerve damage due to high blood glucose (sugar) levels. PDN can bring about symptoms such as burning, stabbing and hypersensitivity in the feet, and can severely limit patients' daily functions.

Unfortunately, even when treated with pain medications, only one in four patients with PDN reports 50 percent relief. Furthermore, PDN is non-discriminatory, in that it lasts through the night. Given the difficulty these patients can already experience in their daily routines, what can be done to help relieve their pain while they sleep? And perhaps even provide daytime pain relief as well?

Fortunately, one innovative company understands the importance of Donne's sentiments, especially for PDN patients. That company is NeuroMetrix, Inc., a medical device company headquartered in Waltham, Massachusetts, focused on the neurological complications of diabetes. Its team, led by Chief Executive Officer Shai N. Gozani, M.D., Ph.D., has created the SENSUS™ Pain Management System, to help those who suffer from PDN find rapid, non-narcotic pain relief both while awake and during sleep—or "pain's easiest salve," as Donne would say.

As Dr. Gozani explains, "The sleep cycle is essential for the repair, rebuilding and recharging of the human body and its natural systems. For the millions who are afflicted with PDN, pain symptoms can actually worsen at nighttime, according to studies published in medical journals."

SENSUS is a lightweight, wearable transcutaneous electrical nerve stimulation (TENS) device that provides fast-acting pain relief as a complement to pain medications. It's the first such device to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use during sleep.

For more on how to manage PDN with SENSUS, ask your doctor, or visit www.neurometrix.com, which paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
2. Treating Poison Ivy Is A Snap! New Cortizone 10 Poison Ivy Relief Pads Launch Just In Time For Summer
3. BioElectronics Enters Malaysias Pain Relief Market
4. BioElectronics Unique Pain Relief Product Featured on Leading Healthcare Show in Spain
5. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
6. Timely Analysis of Pain Relief Costs and Outcomes Finds Disproportionate Risks for Seniors
7. Breakthrough Procedure Provides Relief for Acid Reflux
8. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
9. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at ReportsnReports.com
10. Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. North America Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Other
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 ReNeuron reported in December 2016 ... chronic stroke patients, despite not meeting the three-month time frame ... Action Research Arm Test (ARAT). As a result, the company ... clinical study in 2017. Beyond CTX, we expect safety and ... and Phase I data from its critical limb ischaemia (CLI) ...
(Date:3/22/2017)... -- ReportsnReports.com adds Global Vagus Nerve Stimulation ... global vagus nerve stimulation market analyst says one trend ... invasive VNS procedures. Few years ago, VNS procedures were ... high standards of healthcare infrastructure. ... Browse 30 Exhibits, ...
(Date:3/22/2017)... , March 22, 2017 Ampio ... the development of Ampion™, a low molecular weight ... today announced that it is re-issuing its previous release ... incorporate certain disclosures that are required under the ... below are these additional disclosures along with the ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of ... the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient ... contributed not only to the association, but also to the Health Care Quality and ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, ... ET, http://www.fdanews.com/mdclineval                  , How will the new EU MDR language ...
(Date:3/23/2017)... ... ... and Back”: a true-life testimony of tragedy and the miraculous power of God to ... mother and grandmother committed to sharing her many spiritual adventures which affirm God’s grace ... actual events in the life of her family, which validate her deep faith in ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To ... Response To Atheist Manifesto” is the creation of published author Richard Hostetter, a ... sixty years. He holds graduate degrees from Kent State University and the University ...
Breaking Medicine News(10 mins):